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Y. Tshomba,* G. Melissano, E. Civilini, F. Setacci and R. ChiesaVita-Salute University, Scientific Institute H. San Raffaele, Milan, ItalyObjective. To analyse the fate of a visceral aortic patch (VAP) in patients that underwent thoracoabdominal aortic aneurysm
(TAAA) repair.
Methods. We reviewed 204 consecutive patients (158 M, 46 F) treated for TAAA between 1988 and 2004. We performed
VAP in 182 cases. Among the 149 survivors at 6 months, we followed 138 cases, mean follow-up 7 years (range 0.6–16
years). The mean graft diameter we used was 29 mm (range 24–34 mm) from 1988 to 1999 (83 patients), and 21.7 mm
(range 16–24 mm) from 2000 to 2003 (55 patients). In 23% of cases we performed a separate bypass to the left renal artery.
Results. We observed 16 (12%) VAP dilatations (!5 cm), 6 (4%) VAP aneurysms (O5 cm) and one VAP pseudoaneurysm,
at a mean time of 6 years after atherosclerotic TAAAwas atherosclerotic repair. There were no VAP dilatations/aneurysms in
the group of patients with separate left renal revascularization. Five VAP aneurysms were treated electively. In four cases the
operation was performed with thoracophrenolaparotomy, in one case with a bilateral subcostal laparotomy. In all cases the
visceral aorta was re-grafted. Reimplantation of a single undersized VAP was performed in one case, separate
revascularization of visceral arteries was performed in the other four cases. Selective intraoperative hypothermic perfusion of
visceral and renal arteries was used in all the patients. There was 1 perioperative death; 2 patients with preoperative renal
failure required dialysis. The last VAP aneurysm has remained asymptomatic and stable at annual CTsurveillance. The VAP
pseudoaneurysm was successfully treated with an emergency thoracophrenolaparotomy and refashioning the left side suture
line.
Conclusions. Aneurysm of VAP is not uncommon in the patients operated on using larger grafts with a single VAP that
includes the LRA (7.4%, 5/67 cases). Its treatment carries significant morbidity and mortality.Keywords: Thoracoabdominal aneurysm; Complication; Reintervention; Visceral patch; Aortic reoperation.Introduction
Thoracoabdominal aortic aneurysms (TAAA) have an
ominous natural history,1–3 surgical treatment greatly
improves the long term prognosis; a significant price,
however, is paid both in terms of perioperative
mortality and morbidity, including paraplegia, renal
insufficiency etc.4–8 As opposed to abdominal aortic
aneurysms (AAA) and thoracic aortic aneurysms
(TAA), TAAA have not yet benefited much from the
advent of endovascular techniques for the exclusion of
the aneurysm, in spite of anecdotal reports with
existing materials and interesting research on new: TAAA, thoracoabdominal aortic aneurysm; VAP,
c patch; CT, celiac trunk; SMA, superior mesenteric
right renal artery; LRA, left renal artery; MOF, multiple
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reconstruction is still the preferred treatment for
TAAA.
After surgical treatment patients are generally
enrolled in a follow-up program in order to evaluate
their general conditions risk factors and compliance
with medical therapy; moreover, the evolution of the
grafts, the untreated aorta and other specific arterial
locations (carotid arteries, lower limb arteries, etc.), are
followed with non-invasive diagnostic techniques.
Previous literature reports have showed that when
the renal and splanchnic vessels are attached to the
aortic graft as a single visceral aortic patch (VAP) or
‘Carrell patch’, this may progress into a dilatation or a
frank aneurysm. Anastomotic pseudoaneurysms also
may develop at this site and have distinctive features.
In our experience several cases of both symptomatic
and asymptomatic dilatations, aneurysms and pseu-
doaneurysms have been observed during the long-
term follow up of patients surviving surgery forEur J Vasc Endovasc Surg 29, 383–389 (2005)
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frequency of dilatations, aneurysms or pseudoaneur-
ysms of the VAP, to evaluate their relationship
between the type and time of TAAA surgery and
finally to discuss the surgical treatment and outcome
of this challenging medical condition.Materials and Methods
We reviewed 204 consecutive patients (158 M, 46 F,
mean age 66.3G8.1 years) treated for TAAA between
1988 and 2004 at the IRCCS San Raffaele. In 182 cases a
visceral aortic patch (VAP) was anastomosed to the
aortic graft with the Crawford inclusion technique.13
Patients receiving a distal or proximal bevelled
anastomosis including visceral vessels, patching of the
aorta without tube-graft or single-vessel visceral
grafting were excluded from this study. Among
patients receiving VAP, 149 (82%) survived at a
follow-up greater than 6 months. 138 patients com-
plied with postoperative surveillance. We recorded
and analyzed data from these 138 patients that had
been regularly followed-up (mean follow-up 7.3 years,
range 0.6–16 years).
Our preferred surgical technique for TAAA repair
with left heart bypass, selective visceral perfusion and
cerebro-spinal fluid drainage has been fully described
elsewhere.14,15 We used Dacron woven double velour
soaked in collagen. The mean graft diameter was
29 mm (range 24–34 mm) from 1988 to 1999 (83
patients), and 22 mm (range 16–24 mm) from 2000 to
2004 (55 patients). In 107 patients (77.5%) the relative
proximity of visceral vessels allowed us to create a
four-vessels VAP, in the other 31 cases (23%), the
ostium of the visceral arteries, in particular the left
renal artery (LRA), was set apart from the aneurysm
and required individual anastomosis, either directly or
using a graft. The presence of a severely calcified aorta
required an endarterectomy of the VAP in 16 cases and
open stenting of visceral vessels ostia in three cases.
Visceral aortic patch was routinely reimplanted to the
aortic graft with running polypropylene sutures (2/0
or 3/0) reinforced with pledgets (teflon) at points of
maximum tension. Follow-up included clinical and
radiological examination: chest X-ray, CT or MR scans
at 3 and 6 months after surgical procedure and
thereafter annually using CT or MR.
For operated patients, we defined as a VAP
dilatation an increase in the maximum aortic diameter
greater than 20% compared to the diameter measured
at the first follow up image at the level of visceral
vessels. We defined as VAP aneurysm as having a
diameter of 5 cm or more. This definition of VAPEur J Vasc Endovasc Surg Vol 29, April 2005dilatation, was used in order to correct the possible
errors related to the diameter of the graft used in the
first operation. The diagnosis of VAP pseudo-aneur-
ysm was clinical and histological from operative
specimens.Results
Among the 138 patients that were regularly followed,
we observed 16 (12%) VAP dilatations (!5 cm), 6 (4%)
VAP aneurysms (O5 cm) and 1 (1%) VAP pseudoa-
neurysm (Fig. 1). In all cases that developed a VAP
dilatation or aneurysm, the original TAAA was
atherosclerotic. There were no VAP dilatative lesions
in the group of patients with separate revasculariza-
tion of the left renal artery (LRA).
The mean VAP dilatation diameter was 4.3 cm. All
16 patients of this group were symptom free and were
being regularly followed with yearly (Table 1) CT
scanning. In this group the original TAAA repair was
performed in nine cases for a Crawford type III, in four
cases for a Crawford type II and in three cases for a
Crawford type IV. The mean graft diameter implanted
during the original TAAA repair was 29G3 mm. The
mean time of detection of aneurysmal expansion was
6.2G2.5 years after the original operation.
The mean VAP aneurysm diameter was 5.9G
1.1 cm. In these 6 patients (Table 2) the original
TAAA repair was performed in four cases for a
Crawford type III, in one case for a Crawford type II
and in one case for a Crawford type IV. The mean graft
diameter implanted during the original TAAA repair
was 3.0G0.3 cm. The mean time of detection of
aneurysmal expansion was 5.8G2.3 years after the
original operation. Five patients were symptom free
with lesion detected on routine CT scans. One patient
had back pain. One symptom free patient with a VAP
aneurysm size of 52 mm that had been stable for 6
years is still being followed up. The other 5 patients of
this group have had surgical repair. In four cases the
operation was performed with thoracophrenolapar-
otomy, in one case with a bilateral subcostal lapar-
otomy. In all cases the visceral aorta was re-grafted.
Re-implantation of a single undersized VAP was
performed in one case, placing the suture in the
orifices of the vessels (Fig. 2); LRA was separately
reimplanted in two cases, the right renal artery in
another one and selective bypass grafts were per-
formed in the other case.
We performed intra-operative hypothermic per-
fusion of the celiac and superior mesenteric arteries
with cold crystalloid solution (Lactate Ringer at 4 8C)
and of the renal arteries with cold crystalloid solution
Fig. 1. Follow-up of a patient ((1) who developed a VAP aneurysm. (a) MR that shows the successful type III TAAA repair 1
month after surgical procedure. (b) The same patient at 4-year follow-up: MR scans reveal a dilatation of the visceral patch.
(c) MR taken 1 year later revealed the progressive enlargement of the VAP that became symptomatic.
Fate of Visceral Aortic Patch 385(Lactate Ringer at 4 8C) supplemented with mannitol
and methylprednisolone. No cerebrospinal fluid drai-
nage was used. One case postoperative anuria was
observed and successfully treated with bilateral renal
artery stenting. There was 1 perioperative death due to
multi-organ failure; 2 patients with pre-operative renal
failure required temporary postoperative dialysis. The
four survivors are alive and well after a mean follow
up of 2G0.8 years.
The patient with the VAP pseudoaneurysm was
originally treated for a Crawford class III TAAA. The
graft diameter implanted during the original TAAA
repair was 2.0 cm. He presented with rupture of the
suture line, hemodynamic instability, and a large
pseudoaneurysm 2 years following first operation
(Fig. 3). The VAP pseudoaneurysm was successfullyTable 1. Preoperative characteristics of the patients of this series
Age (years) 66G8
Males 112 (81%)
Maximum diameter (mm) 68G21
Type II TAAA 53 (38%)
Type III TAAA 57 (41%)
Type IV TAAA 28 (20%)
Emergency 11 (8%)
Symptomatic 30 (22%)
Etiology
Degenerative 115 (83%)
Dissection 14 (10%)
Marfan 9 (7%)
Diabetes 12 (9%)
Hypertension 81 (59%)
Cigarettes smoke 73 (53%)
Dislipidemia 26 (19%)
Chronic renal failure 39 (28%)
CAD 84 (61%)
COPD 79 (57%)treated with an emergency operation through a left
thoracophrenolaparotomy. Selective intraoperative
hypothermic perfusion of the visceral and renal
arteries was used, refashioning the left side of suture
line with polypropylene 2/0. The time of total visceral
ischemia was of 14 min. No cerebrospinal fluid
drainage was used. Microbiological study of the
graft, suture and native aortic wall did not show any
bacterial growth. After a long hospital stay the patient
was discharged and is alive and well after 2 months.
Larger original grafts, with diameter greater O
2.8 cm, were significantly associated with VAP dilata-
tion (aneurysm, dilatation, pseudoaneurysm) (P!
0.0001, Fisher exact test). Larger original grafts, with
diameter greater O2.8 cm, also were significantly
associated with VAP aneurysm/pseudoaneurysm
(P!0.04, Fisher exact test).Discussion
Since Crawford proposed his ‘inclusion technique’ for
treatment of TAAA in 1978,13 the results of this
operation improved considerably, with the use of
adjunctive procedures such as distal aortic perfusion,
selective visceral perfusion and cerebro-spinal fluid
drainage.16–19 Nevertheless several studies have
demonstrated that survival after TAAA repair is
worse than survival in the general population.20–22
This might be explained by the invasiveness of this
surgical procedure. Moreover these patients often
present severe comorbidities. Finally, late events may
be related to the ongoing aortic disease. In fact,Eur J Vasc Endovasc Surg Vol 29, April 2005
Table 2. Features of original TAAA repair
Patient Age Sex TAAA
diameter
(mm)
Crawford
type
Graft
diameter
(mm)
Revised
patch
Death Renal com-
plications
Visceral
compli-
cations
1 71 M 64 3 32 CT,
SMA,RRA,
LRA
No Yes No
2 77 M 58 2 28 SMA, CT,
RRA
No No No
3 72 M 52 3 34 CT, SMA,
LRA
Yes (MOF) Yes No
4 67 F 68 3 26 CT, SMA No No No
5 68 M 56 4 28 Selective
bypasses
No No No
6 74 M 54 3 20 CT, SMA,
RRA, LRA
No No Yes
Patients underwent operation for VAP pathology (aneurysm or pseudoaneurysm) developed after a primary TAAA repair.
Y. Tshomba et al.386patients with extensive TAAA generally exhibit a
tendency to aneurysmal degeneration at other sites;
this is most common in patients with connective tissue
disease or dissection.23,24
Revascularization of visceral arteries is a crucial
step of Crawford’s inclusion technique, mainly
because of the limited ischemic tolerance of the
different organs. The most simple and expeditious
surgical technique is to anastomose the graft with an
aortic patch containing all visceral branches. The main
advantage of this technique is the reduced number of
anastomoses. The tissue of VAP however, is excised
from aneurysmal aorta. Although Crawford’s tech-
nique appears to give durable results for most
patients, Dardik, Carrel and Clouse described aneur-
ysmal degeneration and rupture of the VAP.25,26,27
Moreover some authors also report this problem in the
intercostal patch in patients undergoing TAAA25,28
and specific technique of repair have been proposed at
this level.29
To make the size of VAP as small as possible and to
benefit from the greater strength of the aortic tissues
near side branches,30 several authors suggest inten-
tionally placing some bites of the running suture in the
orifices of celiac and renal arteries. However,Fig. 2. (a) Refashioning of a single undersized VAP. Of note the
four visceral vessels. (b) Successful repair of the VAP aneurysm
Eur J Vasc Endovasc Surg Vol 29, April 2005sometimes this manoeuvre may be hazardous because
of the risk of focal ostial plaque disruption and
dissection. This may lead to visceral and/or renal
arteries malperfusion as described in previous
reports.31
In order to reduce the size of VAP, separate
reimplantation of the LRA may be employed, directly
or interposing a graft. Separate reimplantation of each
visceral artery could be used in patients with higher
risk of VAP dilatation and/or widely displaced
visceral ostia. In patients with Marfan syndrome Safi,
proposes the use of side-arm commercially available
grafts during original TAAA repair because of the high
incidence of VAP aneurysm in his experience (25%).27
In patients with Marfan syndrome, Dardik et al.25
purpose a separate bypass to celiac, to the left renal,
and tailoring of a very small VAP including superior
mesenteric and right renal arteries. When not possible
they suggest individual grafts. In these cases the
visceral revascularization procedure may be techni-
cally more complicated. The time of ischemia may be
longer because of the increased number of anasto-
moses. The risk of bleeding and of branch occlusion
may be increased.
The growth rate and risk of rupture of VAPoriginal graft (arrows) and the selective cold perfusion of the
with a 22 mm Dacron graft.
Fig. 3. (a) Emergent CT taken in patient (6 referred to our ER
after hemorrhagic shock. The scan reveals the VAP pseudo-
aneurysm and a retroperitoneal haematoma dislodging the
left kidney. (b) 3-D spiral CT showing successful repair of the
VAP pseudo-aneurysm.
Fate of Visceral Aortic Patch 387dilatations and aneurysms are currently unclear. The
natural history of the graft may play a role in this late
complication. Dacron prostheses in humans have been
documented to develop long-term fiber alterations,
that may account for late graft dilatation.32,33 Late
dilatation has been documented mainly in knitted
prostheses, implanted in the abdominal and thoracic
aorta. During recent years, the manufacturers have
improved their grafts. A recent prospective study
reported that the Dacron woven double velour
collagen-impregnated prostheses implanted in thor-
acic aorta have no significant changes in computed
tomography diameter throughout the first 3 year
follow-up.34 In our series, we did not observe
significant dilatation of the tube-grafts far from aortic
anastomoses. Interestingly, we observed that from the
first postoperative image study, the measured graftdiameter was always larger compared to the nominal
graft diameter (range 2–4 mm), but later the diameter
stabilised. Future evaluations should focus on very
long-term results.
It may be hypothesized that VAP aneurysms behave
like saccular aneurysms25 and present a higher risk of
rupture compared to fusiform aneurysms.35 The
ruptured VAP reported by Dardik occurred at a
diameter greater than 6 cm. The appropriate threshold
has to be assessed and further experience is required to
establish if it criteria should be modified in presence of
connective tissue disorders or other risk factors.
Repair of VAP lesions may not be standardized
because of the small number of cases reported by the
different group and heterogeneous results. Dardik
reports in all his cases a large amount of inflammation
around the VAP that is ‘tremendously difficult to
dissect’.25 He performed VAP repair replacing a
segment of thoracoabdominal aortic prosthetic graft
and refashioning a smaller patch, placing the sutures
in the ostia of vessels. The LRA was reimplanted
separately in all cases, the right renal artery in one
case. He performed distal aortic perfusion but he did
not use visceral or renal perfusion. He controlled
black-bleeding from visceral ostia with intraluminal
occlusion catheters. He did not report postoperative
renal failure but a lengthy and expensive hospitaliz-
ation. Yue et al. also reported a case of VAP aneurysm
repair using the same strategy and refashioning a
smaller VAP.31
Lombardi converted 3 patients with VAP aneurysm
from inclusion technique to separate bypasses to each
vessel in the degenerated patch.36 He preferred to use
profound hypothermic circulatory arrest, because it
provides additional visceral and renal protection
during individual reconstruction of visceral vessels.
Dias and Coselli reported a VAP aneurysm success-
fully treated with interpositioning of a branched aortic
vascular graft used for reinsertion of abdominal
vessels.37 The procedure was performed with cere-
brospinal fluid drainage and renal perfusion with
intermittent cold crystalloid solution.
Carrel reported a case of VAP rupture in a patient
with Marfan syndrome successfully treated with an
interesting strategy.26 In order to minimize ischemic
time of the abdominal organs, he implanted end to
side three separate grafts into the side clamped
thoracic segment of the previous aortic graft. Only
after this manoeuvre he cross-clamped the abdominal
segment of aortic graft, removed the VAP and
performed selective bypasses to the visceral vessels.
Finally the abdominal segment of the thoracoabdom-
inal graft was replaced. Because the left kidney was
atrophic its revascularization was judged unnecessary.Eur J Vasc Endovasc Surg Vol 29, April 2005
Y. Tshomba et al.388Endovascular techniques may also play a role in
VAP pathology treatment. Juvenon et al. proposed
combined surgical and endovascular treatment:38 a
retrograde revascularization of the visceral vessels
was performed and a stent-graft was inserted into the
aortic graft. This procedure is feasible and attractive in
selected patients but long-term results and indications
have to be assessed. Badran et al. successfully
performed transluminal occlusion with thrombin
injection of a pseudoaneurysm arising from an aortic
patch containing intercostals arteries.39
Visceral aortic patch pseudoaneurysms are different
lesions from VAP true aneurysms.22,26 These are
generally contained rupture by the inclusion tech-
nique and are not necessarily related to progressive
VAP dilatation. The VAP pseudoaneurysm that we
observed in our series was probably associated with
VAP anastomotic suture line (polypropylene 3/0)
rupture, as assessed intraoperatively. The VAP wall
was particularly calcified and this may have led to
suture damage at the time of initial surgery and late
rupture in absence of VAP dilatation.
Aneurysm and dilatation of VAP was not uncom-
mon in our series of patients operated for athero-
sclerotic TAAA, with a single VAP that included the
LRA (7.4%, 5/67 cases). Careful postoperative yearly
CT surveillance is recommended.
In our experience graft size has emerged as a risk
factor for dilatating VAP pathology. Laplace’s law
states that wall tension is directly proportional to
diameter. Previous reports did not correlate VAP
expansion to the size of the graft. In our experience
VAP aneurysms were more common in larger diam-
eter grafts. We believe that the use of smaller diameter
grafts may reduce the wall stress and the risk of VAP
dilatation and VAP suture line rupture. Further
evaluation will be required to assess the real impact
of graft diameter on the risk of VAP dilatating disease.
To investigate the effects of different graft sizes in
terms of mechanical stress and strain on VAP wall, we
are performing computational simulations with
models of variously shaped VAP.
Repair of VAP aneurysm carried significant mor-
tality and morbidity. The adjunctive procedures
experienced in TAAA type IV40,41 may be successfully
employed in VAP aneurysm repair.References
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